Peptide Knowledge Base · Hormonal
Enclomiphene: what it is, what the evidence says, and its real status
An oral medicine, not a peptide, that raises the body's own testosterone, a fertility-sparing alternative to TRT.
Short version: not a peptide, an oral SERM that nudges your own testosterone up while preserving fertility. By request, clinician-evaluated.
Can you actually get it?
Plain-English verdict: Waitlist.
Regulatory status: By request · SKU request.
By request, clinician-evaluated. Enclomiphene is an oral SERM (not a peptide) that raises endogenous testosterone while preserving fertility, an alternative to traditional TRT. Eligibility is a clinical decision.
How does Enclomiphene work?
A selective estrogen receptor modulator that increases LH/FSH, raising the body's own testosterone production.
What it does — and what it does not do
What it does: Raises endogenous testosterone while preserving sperm production.
What it does not do: It is not a peptide and not a substitute for evaluation of the cause of low testosterone.
How honest is the evidence?
Evidence grade B — controlled human trials for raising endogenous testosterone. Read our grading methodology for what each grade means.
What we still don't know: Long-term outcome data beyond testosterone levels is still maturing.
WADA status: Banned (S4).
How it is taken
Clinician-set; oral. Educational only.
Who should not take it
Banned in tested sport (WADA S4); clinician evaluation for the cause of hypogonadism required.
Sources
Enclomiphene citrate endogenous-testosterone trials
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.